Mestre e PhD em Bioquímica
Envie uma proposta de trabalho diretamente para este candidato
Graduated in Pharmacy from Instituto Educacional Santo Agostinho (2015). She participated in research projects related to quality control of medicines and medicinal plants. He completed an extra-curricular internship at Faculdade Santo
Agostinho (856 hours), being responsible for organizing the laboratories, preparing solutions and reagents and assisting in research for the institution's students' final coursework. She worked in a private pharmacy in the Municipality of Berizal-MG as a pharmacist responsible for ensuring the management of inputs related to the
Pharmacy, through the development of procedures and team guidance, as well as providing primary care to patients, aiming at the availability of resources, standards quality and effectiveness of treatment. He is currently a Master in the Multicenter
Postgraduate Program in Biochemistry and Molecular Biology at Faculdade Federal de São João Del-Rei where he worked with molecular aspects of tumor evasion of the immune system mediated by detrital cells promoted by the breast cancer cell line MDA-MB- 231. She is also a PhD student in the Postgraduate Program in
Biochemistry and Immunology at the Federal University of Minas Gerais, with PhD defense prediction and obtaining the title in June 2024 online. She has additional training in data science through courses available on the coursera platform in
Python and R and is interested in expanding her knowledge of the broad area of data science applied to oncology. Currently, she is a student in a MBA on Data
Science e Analytics at the University of São Paulo (USP).
-Ensure the management of inputs related to the Pharmacy, through the development of procedures and team guidance
Purification of the synthetic peptide using the HPLC device, and using these peptide to biological assays.
and the electronic microscopy previous preparation for fluorescence microscopy and electronic microscopy analyses.
231 cell line.
During the master degree I elucidated a new mechanism related to dendritic cells,
differentiated from healthy donor monocytes (mo-DCs), immune response tumor invasion through exosomes.
The MDA-MB-231 breast cancer cell line released exosomes able to change mature dendritic cell phenotype, modulating the it’s action to stimulate the T lymphocyte proliferation.
The phenotype profile of dendritic cells was performed by flow cytometry at UFMG.
In addition, exosomes of MDA-MB-231 cell line express MicroRNAs relate to mo-DC response modulation, and mo-DCs after MDA-MB-231 cell line exosomes presented apoptosis genes expression. The miR and apoptosis genes expression were evaluated by RT-qPCR.
